Lexicon Pharmaceuticals LXRX
NASDAQ LXRX
$1.82 -0.05 (-2.93%)
At close: Oct 1, 2026 · 4:00 PM EDT

Lexicon Pharmaceuticals (LXRX) Other Non-Current Assets (2010 - 2026)

Updated

Lexicon Pharmaceuticals (LXRX) reported Other Non-Current Assets of $368,000 for Q2 2026, down 98.7% from $29 million a year earlier and down 98.7% from the prior quarter.

Analysis

Lexicon Pharmaceuticals (LXRX) Other Non-Current Assets (2010 - 2026) Analysis & Trends

At the end of FY2025, Lexicon Pharmaceuticals posted Other Non-Current Assets of $29 million.

  • Other Non-Current Assets has a five-year compound annual growth rate of 88.1% (FY2020 to FY2025).
  • By year, Other Non-Current Assets came in at $368,000 in FY2024 (-55.6%), $828,000 in FY2023 (+101.0%), $412,000 in FY2022 (-81.8%) and $2.27 million in FY2021 (+84.3%).
  • Five-year quarterly Other Non-Current Assets spans a low of $368,000 in Q4 2024 and a high of $29 million in Q1 2026.
  • Year over year, Other Non-Current Assets gained in 1 of the last four quarters, with an average decline of 49.6%.
  • The high point for year-over-year Other Non-Current Assets in five years was Q2 2023 (growth of 238.5%); the low point was Q2 2026 (a decline of 98.7%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $29 million (Q1 2026), $29 million (Q4 2025) and $29 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 14.27 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.73 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.93 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 12.98 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 4.75 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 9.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.25 Bn
10 Lexicon Pharmaceuticals 840.12 Mn 266.67 Mn 653,000.00 368,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 368,000.00
Mar 31, 2026 29.00 Mn
Dec 31, 2025 29.00 Mn
Sep 30, 2025 29.00 Mn
Jun 30, 2025 29.00 Mn
Mar 31, 2025 368,000.00
Dec 31, 2024 368,000.00
Sep 30, 2024 828,000.00
Jun 30, 2024 828,000.00
Mar 31, 2024 828,000.00
Dec 31, 2023 828,000.00
Sep 30, 2023 743,000.00
Jun 30, 2023 6.26 Mn
Mar 31, 2023 6.42 Mn
Dec 31, 2022 412,000.00
Sep 30, 2022 7.15 Mn
Jun 30, 2022 1.85 Mn
Mar 31, 2022 2.06 Mn
Dec 31, 2021 2.27 Mn
Sep 30, 2021 2.47 Mn
API Access

Lexicon Pharmaceuticals Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=LXRX&period=max&api_key=YOUR_API_KEY